-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Gain Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2023.
- Gain Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $8K, unchanged year-over-year.
- Gain Therapeutics, Inc. annual Depreciation for 2023 was $34.9K, a 31% increase from 2022.
- Gain Therapeutics, Inc. annual Depreciation for 2022 was $26.6K, a 72% increase from 2021.
- Gain Therapeutics, Inc. annual Depreciation for 2021 was $15.5K, a 61.4% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)